In a filing, Phio Pharmaceuticals Corp revealed its Chairman, Pres & CEO Bitterman Robert J acquired Company’s shares for reported $4840.0 on Jun 10 ’25. In the deal valued at $2.42 per share,2,000 shares were bought. As a result of this transaction, Bitterman Robert J now holds 27,149 shares worth roughly $50497.14.
Then, Ferrara Robert L bought 2,500 shares, generating $6,050 in total proceeds. Upon buying the shares at $2.42, the Director now owns 15,666 shares.
Before that, Bitterman Robert J bought 1,500 shares. Phio Pharmaceuticals Corp shares valued at $4,125 were divested by the Chairman, Pres & CEO at a price of $2.75 per share. As a result of the transaction, Bitterman Robert J now holds 25,149 shares, worth roughly $46777.14.
A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early August with a ‘”a Buy”‘ rating.
Price Performance Review of PHIO
On Monday, Phio Pharmaceuticals Corp [NASDAQ:PHIO] saw its stock fall -9.27% to $1.86. Over the last five days, the stock has lost -13.97%. Phio Pharmaceuticals Corp shares have fallen nearly -40.95% since the year began. Nevertheless, the stocks have risen 3.33% over the past one year. While a 52-week high of $9.79 was reached on 01/13/25, a 52-week low of $0.97 was recorded on 04/08/25.
Levels Of Support And Resistance For PHIO Stock
The 24-hour chart illustrates a support level at 0.99, which if violated will result in even more drops to 0.12. On the upside, there is a resistance level at 3.46. A further resistance level may holdings at 5.06.
How much short interest is there in Phio Pharmaceuticals Corp?
A steep rise in short interest was recorded in Phio Pharmaceuticals Corp stocks on 2025-10-15, growing by 8454.0 shares to a total of 0.27 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 0.26 million shares. There was a rise of 3.12%, which implies that there is a positive sentiment for the stock.
